- Home
- BAOS vs INM Comparison
BAOS vs INM Comparison
Compare BAOS & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAOS
- INM
- Stock Information
- Founded
- BAOS 2018
- INM 1981
- Country
- BAOS China
- INM Canada
- Employees
- BAOS N/A
- INM 13
- Industry
- BAOS Business Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- BAOS Consumer Discretionary
- INM Health Care
- Exchange
- BAOS Nasdaq
- INM Nasdaq
- Market Cap
- BAOS 4.2M
- INM 5.0M
- IPO Year
- BAOS 2021
- INM N/A
- Fundamental
- Price
- BAOS $3.50
- INM $2.10
- Analyst Decision
- BAOS
- INM
- Analyst Count
- BAOS 0
- INM 0
- Target Price
- BAOS N/A
- INM N/A
- AVG Volume (30 Days)
- BAOS 1.6M
- INM 120.5K
- Earning Date
- BAOS 09-26-2025
- INM 11-13-2025
- Dividend Yield
- BAOS N/A
- INM N/A
- EPS Growth
- BAOS N/A
- INM N/A
- EPS
- BAOS N/A
- INM N/A
- Revenue
- BAOS $624,087.00
- INM $4,942,633.00
- Revenue This Year
- BAOS N/A
- INM N/A
- Revenue Next Year
- BAOS N/A
- INM N/A
- P/E Ratio
- BAOS N/A
- INM N/A
- Revenue Growth
- BAOS N/A
- INM 7.50
- 52 Week Low
- BAOS $1.44
- INM $1.72
- 52 Week High
- BAOS $13.66
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- BAOS 49.50
- INM 43.02
- Support Level
- BAOS $3.56
- INM $2.04
- Resistance Level
- BAOS $5.21
- INM $2.26
- Average True Range (ATR)
- BAOS 0.37
- INM 0.14
- MACD
- BAOS -0.02
- INM -0.01
- Stochastic Oscillator
- BAOS 16.50
- INM 13.05
About BAOS Baosheng Media Group Holdings
Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.